Overview
Benhui Liang practices practicing medicine in Changsha, China.
Their clinical expertise encompasses Hypertension, Pulmonary Hypertension, Heart Failure, and Acute Coronary Syndrome.
They are actively involved in clinical research, co-authoring 24 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Benhui Liang
Is Benhui Liang a top-rated expert for Hypertension?
MediFind is an objective health platform that identifies experts based on real-world data. Benhui Liang is classified as an Experienced expert for Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Benhui Liang participate in research or clinical trials?
Yes. Benhui Liang has published 24 articles and abstracts on conditions like Hypertension. You can view a list of Benhui Liang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Coronary SyndromeLiang isExperienced. Learn about Acute Coronary Syndrome.
- Heart FailureLiang isExperienced. Learn about Heart Failure.
- HypertensionLiang isExperienced. Learn about Hypertension.
- Pulmonary HypertensionLiang isExperienced. Learn about Pulmonary Hypertension.